Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) releases its Q4 earnings later this month and investors are hoping a good result can help generate some excitement around the stock.

| More on:

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to be releasing its quarterly earnings later this month. And with its share price struggling since May, investors might be tempted to buy the stock before it announces its year-end results. Let’s take a closer look at the company to see whether it’s a good idea to buy now.

In its last earnings release back in February, Canopy Growth recorded significant sales growth numbers yet again. However, with a lot of cash burn and soaring expenses, there were plenty of red flags that kept the stock from gaining any momentum. The danger is that in Q4 it could be much of the same, as Canopy Growth has been very busy wheeling and dealing, which is sure to add some significant costs along the way, potentially sending the company  even deeper into the red.

While Canopy Growth is playing the long game and looking to strengthen its position over the years, in the short term, it’s going to lead to a lot of pain. However, investors are aware of these challenges and likely aren’t expecting the company to produce an (operating) profit anytime soon. Otherwise, Canopy Growth wouldn’t be at a market cap of around $20 billion today.

Is excitement surrounding Canadian pot stocks fading?

The big risk for Canopy Growth isn’t related to its financials or whether it will meet expectations; rather, it’s that investors have so many more options to choose from, as the U.S. cannabis industry has been growing and capturing a lot of attention lately. There’s no denying that the opportunity south of the border is a lot more lucrative given how strong sales have been in California and in other states.

While Canopy Growth certainly looks to capitalize that through its plans for hemp and the acquisition of Acreage Holdings, it’s still a long-term play that could take years to be realized. Meanwhile, companies in the U.S. are already expanding their reach throughout the country.

In order for investors to get excited about Canopy Growth, the company will have to announce some progress or expectations for its plans for the U.S. because strong results in Canada may not be enough to lift the stock from where it is today. Industry developments or company announcements have typically given Canopy Growth a big boost in the past. Investors have looked for signs of the growth that might be coming down the pipe rather than what has already been achieved thus far.

Bottom line

Barring a significant announcement made at the Q4 release, I would be surprised if the company sees a big boost in its share price even after a strong earnings result. However, given we’ve seen many misses in the industry since legalization, I wouldn’t hold out hope that Canopy Growth will produce a positive surprise this time around.

It may not be until edibles are legalized until we see some excitement returning to Canadian pot stocks. For now, however, the focus appears to have shifted away, and while that might make Canopy Growth an appealing buy today given its softer price, I wouldn’t expect the stock to get a big boost after the company releases its earnings this month.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »